Skip to content

Is TRT good for aging men?: Evaluating benefits and risks

3 min read

Over 20% of men aged 60 to 80 may experience hypogonadism, or low testosterone, making many wonder, is TRT good for aging men? While testosterone replacement therapy (TRT) can offer significant improvements in sexual function, mood, and body composition for those with a clinically-diagnosed deficiency, its effectiveness and safety for age-related decline, and not true hypogonadism, remain highly debated.

Quick Summary

This article explores the pros and cons of testosterone replacement therapy (TRT) for older men. It details the potential benefits for those with confirmed hypogonadism, including improved libido and muscle mass, but also outlines serious health risks like cardiac events and polycythemia. The piece emphasizes the necessity of a clinical diagnosis and individualized risk assessment before beginning treatment.

Key Points

  • Not for normal aging: TRT is only approved by the FDA for men with a diagnosed medical condition of low testosterone (hypogonadism), not for general age-related decline.

  • Benefits for confirmed hypogonadism: For those with a clinical deficiency, TRT can improve sexual function, boost bone density and muscle mass, and elevate mood.

  • Cardiovascular risks require caution: The TRAVERSE trial showed no increased risk of heart attack or stroke but a higher risk of atrial fibrillation and pulmonary embolism, especially for men with pre-existing heart conditions.

  • Prostate health must be monitored: TRT can accelerate existing prostate cancer and lead to benign prostatic enlargement. Regular PSA testing and prostate exams are essential.

  • Blood thickening is a common risk: Polycythemia, an increase in red blood cell count, is a frequent side effect that requires careful monitoring due to the risk of blood clots.

  • Decision is highly individualized: The choice to start TRT should be a shared decision between a patient and their doctor, based on a comprehensive health assessment and a realistic understanding of benefits and risks.

  • Long-term safety is still under investigation: While recent studies offer some reassurance on cardiovascular risks, long-term, multi-decade safety data for older men on TRT is still limited.

  • Alternative health strategies exist: For those with age-related decline rather than a diagnosed medical condition, lifestyle modifications like exercise and weight loss are safer and effective ways to boost endogenous testosterone.

In This Article

What is age-related testosterone decline?

As men age, their testosterone levels naturally decline. This differs from hypogonadism, a medical condition where the body doesn't produce enough testosterone. TRT is FDA-approved for hypogonadism but not for normal aging symptoms, which can overlap, making diagnosis crucial.

The crucial difference between aging and hypogonadism

Differentiating age-related decline from true hypogonadism is vital. Only a confirmed diagnosis of hypogonadism, based on blood tests and symptoms, warrants TRT. Treating aging symptoms with TRT is not recommended due to unproven benefits and potential risks.

Potential benefits of TRT for aging men with hypogonadism

For older men with diagnosed hypogonadism, TRT can improve quality of life. Benefits are less clear in men with normal or slightly low testosterone.

  • Improved sexual function: TRT can boost sexual desire and erectile function in older men with low testosterone.
  • Enhanced bone density: TRT may increase bone density, reducing fracture risk. However, one study noted a higher fracture rate in the TRT group.
  • Increased muscle mass and strength: TRT can increase lean mass and strength, potentially improving physical function in older adults.
  • Better mood and energy: TRT may modestly improve mood and vitality in men with low testosterone.

Significant risks and side effects of TRT

TRT has risks, especially for older men with other health issues. Discuss these thoroughly with a doctor.

  • Cardiovascular events: A large trial (TRAVERSE) found no increased heart attack or stroke risk, but higher rates of atrial fibrillation and pulmonary embolism. Caution is needed, particularly with pre-existing heart conditions.
  • Prostate health concerns: TRT doesn't cause prostate cancer but can accelerate existing cancer growth. It can also enlarge the prostate, causing urinary issues. Regular PSA monitoring is essential.
  • Polycythemia (increased red blood cells): This common side effect thickens blood, increasing clot risk. Hematocrit levels need monitoring, and therapy may be paused if levels are too high.
  • Other side effects: These include acne, fluid retention, breast enlargement (gynecomastia), testicular shrinkage, and potentially worsening sleep apnea.

Comparison of TRT effects on younger and older hypogonadal men

Feature Younger Hypogonadal Men (< 65) Older Hypogonadal Men (≥ 65)
Effectiveness Benefits often more pronounced and consistent across many parameters, including muscle mass and energy. Effects may be more modest and vary more between individuals. Some benefits, like those for sexual function, are clearer than others.
Risks Generally fewer overall health comorbidities. Risks like polycythemia and prostate changes are still present but may be less complicated by existing conditions. Higher prevalence of chronic conditions like heart disease, diabetes, and pre-existing prostate issues, which can increase susceptibility to TRT's adverse effects.
Cardiovascular Risk The overall risk profile is considered more straightforward, though still requires monitoring. More nuanced risk profile due to age-related changes. Recent large trials provide some reassurance but still highlight risks like atrial fibrillation and pulmonary embolism.
Prostate Risk Still require prostate monitoring, but the prevalence of subclinical prostate cancer is lower. Higher baseline risk of subclinical prostate cancer, requiring careful screening and monitoring.
Decision Making Often a more clear-cut risk/benefit analysis based primarily on hypogonadism symptoms. Requires a highly individualized approach, weighing symptomatic burden and personal risk tolerance against uncertain long-term effects.

Making an informed decision about TRT

The decision to use TRT, especially for aging men, requires careful consideration with a healthcare professional. A thorough evaluation is needed to confirm hypogonadism, rule out other causes, and assess individual risks. Be realistic about outcomes and understand that TRT is typically a long-term treatment with ongoing monitoring.

Conclusion: A personalized approach is key

Is TRT good for aging men? It depends on the individual. For older men with confirmed hypogonadism, TRT can help with symptoms like low libido and muscle loss, but risks like heart and prostate issues must be managed. TRT is not recommended for general age-related symptoms. Discuss your health profile with your doctor to weigh benefits against risks. Healthy lifestyle choices like diet and exercise can also help manage aging symptoms.

EMAS position statement: Testosterone replacement therapy in older men with late-onset hypogonadism (LOH) is a clinical guideline document from the European Male Ageing Study (EMAS) providing recommendations on TRT use in aging men with LOH.

Frequently Asked Questions

No, the FDA has not approved TRT for reversing or treating normal aging. The gradual decline in testosterone that occurs with age is different from a medical condition called hypogonadism. While TRT can improve symptoms of hypogonadism, using it for general aging is not medically advisable and lacks evidence.

Age-related low testosterone is a natural, gradual decline, while hypogonadism is a medical condition where the body cannot produce enough testosterone due to a problem with the testicles or the pituitary gland. A doctor must confirm hypogonadism with multiple blood tests and a clinical evaluation before considering TRT.

For older men with cardiovascular risk, the safety of TRT is a complex issue. A recent large trial found no increased risk of heart attack or stroke but did show a higher risk of atrial fibrillation and pulmonary embolism. Men with a history of heart disease should discuss risks with their cardiologist before starting TRT.

Current research does not show that TRT causes new prostate cancer. However, it can accelerate the growth of existing cancer. For this reason, it is contraindicated in men with untreated prostate cancer and requires careful monitoring via PSA levels and physical exams.

Men on TRT should be monitored regularly by their healthcare provider. This typically involves blood tests to check testosterone, hematocrit, and PSA levels at 3, 6, and 12 months after initiation, and at least yearly thereafter.

Some of the most common side effects include an increased red blood cell count (polycythemia), which raises the risk of blood clots, prostate enlargement (benign prostatic hyperplasia), worsening sleep apnea, acne, and fluid retention. Less frequently, it can cause gynecomastia (breast enlargement) and testicular shrinkage.

Yes. For men without a diagnosed medical condition, many age-related symptoms can be addressed through lifestyle changes. These include regular resistance exercise to increase muscle mass, weight loss, a healthy diet, and addressing nutrient deficiencies. TRT is not recommended for non-specific symptoms of aging.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.